Mizuho Securities Reiterates Buy Rating, $12 PT on IN8bio (INAB), Sees Latest Presentations as "Supportive of INAB's Drug-resistant Immunotherapy Platform"

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Mizuho Securities Reiterates Buy Rating, $12 PT on IN8bio (INAB), Sees Latest Presentations as "Supportive of INAB's Drug-resistant Immunotherapy Platform"
(NASDAQ: INAB) Delayed: 1.10 -0.08 (6.78%)
Previous Close $1.18    52 Week High $ 
Open $1.19    52 Week Low $ 
Day High $1.20    P/E N/A 
Day Low $1.10    EPS $ 
Volume 56,009